Clinical Trials on Small/Large Bowel in Taiwan

Total 694 results

Chang Gung Memorial Hospital

Recruiting

Effect of Laser Acupuncture on Adhesive Small Bowel Obstruction

Adhesive Small Bowel Obstruction

Taiwan
National Cheng-Kung University Hospital

Terminated

Metformin in Stage IV Lung Adenocarcinoma

Non-small Cell Lung Cancer

Taiwan
National Taiwan University Hospital

Completed

Selumetinib in Combination With Gefitinib in NSCLC Patients

Non-small Cell Lung Cancer (NSCLC)

Taiwan
National Taiwan University Hospital

Completed

AUY922 in Patient With Stage IV NSCLC (NSCLC)

Non-small Cell Lung Cancer (NSCLC)

Taiwan
National Cheng-Kung University Hospital

Unknown

Comparison of Cost-effectiveness of Continuation Maintenance Therapy With Six Cycles of Pemetrexed Versus Pemetrexed Until Disease Progression for Metastatic Non-squamous Non-small-cell Lung Cancer

Non-Small Cell Lung Cancer

Taiwan
Ono Pharmaceutical Co. Ltd

Completed

ONO-4538 Study in Patients With Advanced Non-Small Cell Lung Cancer

Advanced Non-small Cell Lung Cancer

Taiwan
Anbogen Therapeutics, Inc.

Recruiting

Phase 1b/2 Study to Evaluate ABT-101 in Solid Tumor and NSCLC Patients

Non Small Cell Lung Cancer | Advanced Solid Tumor | HER2 Mutations

Taiwan
AstraZeneca

Completed

An Observational Study to Evaluate AZD9291 Treatment in Patients With T790M Positive Non-small Cell Lung Cancer

Non Small Cell Lung Cancer

Taiwan
AstraZeneca

Completed

Multicentre Study to Explore the Correlation Between Smoking Pattern and Clinical Efficacy of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) in Male Patients

Non Small Cell Lung Cancer

Taiwan
Daiichi Sankyo, Inc.

Terminated

DS-1205c With Osimertinib for Metastatic or Unresectable Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer

Non-small Cell Lung Cancer (NSCLC)

Taiwan
National Cheng-Kung University Hospital

Unknown

Tailored Second Line Treatment by Epidermal Growth Factor Receptor (EGFR) Mutation in Patients With Advanced Lung Adenocarcinoma

Non-Small Cell Lung Cancer

Taiwan
National Health Research Institutes, Taiwan

Recruiting

The Research Plan of Taiwan Precision Medicine

Non-small-cell Lung Cancer

Taiwan
Changhua Christian Hospital

Completed

Different Dosing Time of Bowklean for the Bowel Preparation

Bowel Preparation

Taiwan
Universal Integrated Corp.

Completed

Study of the Efficacy and Safety of Quiklean® and Klean-Prep With Dulcolax® for the Bowel Preparation Prior to Colonoscopy

Bowel Preparation

Taiwan
Taipei Medical University WanFang Hospital

Completed

Comparing Single-dose Low-volume PEG Plus Bisacodyl vs. Split-dose PEG for Bowel Preparation in Morning Colonoscopy

Bowel Preparation

Taiwan
Taipei Medical University Hospital

Unknown

LINE Re-education Before Colonoscopy to Confirm Optimal Bowel Cleansing

Bowel Cleansing

Taiwan
Pell Bio-Med Technology Co., Ltd.

Recruiting

Long-term Follow-up Study of Lentiviral-based Gene-edited Immune Cell Therapy

Diffuse Large B Cell Lymphoma | Primary Mediastinal Large B Cell Lymphoma | Large B-cell Lymphoma | Follicular Lymphoma Grade 3B | Follicular Lymphoma Grade 3A

Taiwan
Pell Bio-Med Technology Co., Ltd.

Recruiting

Phase 1/2 Study of CD19 Chimeric Antigen Receptor T-cell (CD19 CAR-T; PL001) for Relapsed or Refractory B-cell Lymphoma

Diffuse Large B Cell Lymphoma | Primary Mediastinal Large B Cell Lymphoma | Large B-cell Lymphoma | Follicular Lymphoma Grade 3B | Follicular Lymphoma Grade 3A

Taiwan
SciClone Pharmaceuticals International (Cayman)...
Parexel; National Cheng-Kung University Hospital

Unknown

An Open-Label Phase I/II Clinical Study of PT-112 in Combination With Docetaxel in Subjects With Advanced Solid Tumor in a Phase I Dose Escalation Study and in Subjects With Non-Small Cell Lung Cancer (NSCLC) in a Phase II Dose Confirmation Study

Non-Small Cell Lung Cancer | Advanced Solid Tumor

Taiwan
National Health Research Institutes, Taiwan
National Taiwan University Hospital; Mackay Memorial Hospital; China Medical... and other collaborators

Recruiting

First-line Antibiotic Therapy for Early-stage HP(+) Gastric Pure DLBCL

Gastric Diffuse Large B-cell Lymphoma

Taiwan
Universal Integrated Corp.

Completed

A Study of the Efficacy and Safety of Bowklean and Klean-Prep With Dulcolax for the Bowel Preparation Prior Colonoscopy

Bowel Preparation Before Colonoscopy

Taiwan
Takeda

Completed

A Study of Vedolizumab and Biologic Agents in Participants With Inflammatory Bowel Disease (IBD)

Crohn's Disease | Ulcerative Colitis | Inflammatory Bowel Disease (IBD)

Taiwan
National Taiwan University Hospital

Completed

Effectiveness of Experiential Learning on Dietary Fiber Literacy

Bowel Symptoms | Literacy

Taiwan
Eden BioCell Ltd.
National Taiwan University Hospital

Terminated

RPM CD19-mbIL15-CAR-T Cells in Patient With Advanced Lymphoid Malignancies

Follicular Lymphoma | Mantle Cell Lymphoma | Diffuse Large B Cell Lymphoma | B-cell Acute Lymphoblastic Leukemia | High-grade B-cell Lymphoma | Primary Mediastinal Large B Cell Lymphoma | Non-Hodgkin's Lymphoma, Relapsed | Non-Hodgkin's Lymphoma Refractory

Taiwan
National Taiwan University Hospital

Completed

Polatuzumab Vedotin in Patients With Relapsed and Refractory Diffuse Large B Cell Lymphoma

Refractory Lymphoma | Relapsed Non Hodgkin Lymphoma

Taiwan
AstraZeneca

Completed

Real-world Data on Stage III NSCLC Patients Treated With Durvalumab After Chemoradiotherapy in Asia Area (PACIFIC AA)

Carcinoma, Non-Small-Cell Lung

Taiwan
Novartis Pharmaceuticals

Completed

Study of Safety and Efficacy of LEE011 and Ceritinib in Patients With ALK-positive Non-small Cell Lung Cancer.

Non-small Cell Lung Cancer

Taiwan, Spain, Italy, United States, Korea, Republic of, France
Sanofi

Recruiting

Agalsidase Beta Long-Term Treatment Outcome for Fabry Disease Patients With IVS4 Mutation in Taiwan

Fabry Disease

Taiwan
Air Force Military Medical University, China

Completed

External Validation of a Predictive Model for Bowel Preparation in Patients Undergoing Colonoscopy

Colonoscopy | Bowel Preparation

China
Menarini Group

Withdrawn

12-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D) (IRIS-05)

Irritable Bowel Syndrome With Diarrhea

Taiwan, Singapore, Korea, Republic of
National Taiwan University Hospital

Recruiting

Image-Guided Functional Lung Avoidance Thoracic Radiotherapy for Lung Cancer: A Single-Blind Randomized Trial

Stage III Non-small Cell Lung Cancer | Small Cell Lung Cancer, Limited Stage

Taiwan
Golden Biotechnology Corporation
ICON Clinical Research

Completed

Efficacy, Safety and Pharmacokinetics Study of Antroquinonol to Treat NSCLC

Non-small Cell Lung Cancer Stage IV

United States, Taiwan
AstraZeneca

Completed

Evaluation of Symptoms Improvement in NSCLC Patients With First-Line Therapy of EGFR Tyrosine Kinase Inhibitor

Non-Small-Cell Lung Cancer

Taiwan
Taipei Medical University Hospital
Pfizer; TTY Biopharm

Unknown

Salvage Therapy With Sunitinib,Docetaxel and Platinum on Metastatic or Unresectable Non Small Cell Lung Cancer

Non Small Cell Lung Cancer

Taiwan
National Taiwan University Hospital

Unknown

The Utility and Cost-Effectiveness Analysis of 18F-FDG PETin Staging Potential Operable Non-Small Cell Lung Cancer

Non Small Cell Lung Cancer

Taiwan
National Taiwan University Hospital
National Taiwan University Hospital, Yun-Lin Branch

Unknown

Clinical Application of MR-PET in Non-small Cell Lung Cancer: Diagnosis, Treatment Outcome, and Prognosis Prediction

Non-small Cell Lung Cancer

Taiwan
Golden Biotechnology Corporation
PharmaNet

Completed

Determine MTD and to Evaluate pk, Safety/Tolerability and Efficacy Profiles of Hocena® in NSCLC Subjects (Hocena)

Non-small Cell Lung Cancer

Taiwan
National Taiwan University Hospital

Unknown

Dose Defining Study For MK-2206 Combined With Gefitinib In Non Small Cell Lung Cancer (NSCLC)

Non Small Cell Lung Cancer

Taiwan
National Taiwan University Hospital

Completed

Docetaxel Plus Cisplatin Followed by Gemcitabine Versus Gemcitabine Plus Cisplatin Followed by Docetaxel for Non-Small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer

Taiwan
Chang Gung Memorial Hospital

Completed

Low Dose Weekly Docetaxel Versus Pemetrexed in Previously Treated Advanced Non-Small-Cell Lung Cancer

Non Small Cell Lung Cancer

Taiwan
National Taiwan University Hospital

Unknown

Erlotinib Monotherapy Versus Docetaxel and Cisplatin as Neoadjuvant Therapy in Patients of stageIIIA Lung ca (Oncology)

Non-small Cell Lung Cancer(NSCLC)

Taiwan
Novartis Pharmaceuticals

Active, not recruiting

Study of EGF816 in Combination With Selected Targeted Agents in EGFR-mutant NSCLC

EGFR-mutant Non-small Cell Lung Cancer

Taiwan, Germany, Canada, Italy, Singapore, Hong Kong
National Taiwan University Hospital

Unknown

e- Ab Sensor-based Real-time Detection of Mutant EGFR in Clinical Specimens From Patients of Non-small Cell Lung Cancer

Non-small Cell Lung Cancer (NSCLC)

Taiwan
Chung Shan Medical University

Unknown

A Study of the Correlation Between CRF, Survival and Physiological Factors in NSCLC Patients Under Chemotherapy

Non-small Cell Lung Cancer

Taiwan
Ivy Life Sciences, Co., Ltd
Taipei Veterans General Hospital, Taiwan; Tri-Service General Hospital

Completed

A Study to Evaluate the Safety and Efficacy of Ex Vivo Expanded Autologous Immune Killer Cells (IKC) in Stage IV Non-small Cell Lung Cancer (NSCLC) in Patients Who Failed Chemotherapy or Target Therapy (IVY03)

Non-small Cell Lung Cancer (NSCLC) Stage IV

Taiwan
National Taiwan University Hospital

Unknown

Effects of Nonintubated Thoracoscopic Lobectomy on Lung Protection

Non-small Cell Lung Cancer | Tracheal Intubation Morbidity | Lung Function Decreased

Taiwan
Muhammad

Completed

Effect of Oral Enteral Nutrition on Cerebral Small Vessel Disease

Cerebral Small Vessel Diseases

Taiwan
BeiGene

Recruiting

Treatment of CD79B Mutant Relapsed/Refractory Diffuse Large B-Cell Lymphoma With Bruton Tyrosine Kinase Inhibitor Zanubrutinib

Relapsed Diffuse Large B-cell Lymphoma | Refractory Diffuse Large B-cell Lymphoma

China
Janssen Research & Development, LLC

Completed

A Study to Evaluate the Clinical Efficacy of JNJ-42756493 (Erdafitinib), A Pan-Fibroblast Growth Factor Receptor (FGFR) Tyrosine Kinase Inhibitor, In Asian Participants With Advanced Non-Small-Cell Lung Cancer, Urothelial Cancer, Esophageal Cancer Or Cholangiocarcinoma

Neoplasm

China, Taiwan, Korea, Republic of
Tzu Chi University

Unknown

Baduanjin Exercise on Meridian Energy, Lung Function and Heart Rate Variability in Patients Undergoing Lung Operative.

Lung Cancer Non Small Cell

Taiwan

3

Subscribe